)
)
Carisma Therapeutics Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Carisma Therapeutics Inc
Access all reports
Carisma Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing immunotherapies using its proprietary macrophage and monocyte cell engineering platform. The company's primary aim is to create treatments for cancer and other serious diseases by leveraging engineered macrophages and monocytes to attack and eliminate tumor cells. Carisma's product candidates include ex vivo gene-modified autologous chimeric antigen receptor-monocyte (CAR-Monocyte) and CAR-macrophage (CAR-Macrophage) cellular therapies designed to treat solid tumors that overexpress specific markers such as HER2. The company is headquartered in Philadelphia, PA, and its shares are listed on the NASDAQ.
Key slides for Carisma Therapeutics Inc
Corporate Presentation
Carisma Therapeutics Inc
Corporate Presentation
Carisma Therapeutics Inc
Latest articles
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
Ticker symbol
CARM
Country
🇺🇸 United States